Remove Antibody Remove Branding Remove Immune Response
article thumbnail

Keeping tabs on Covid-19: UK firm tests oral delivery of Covid-19 vaccine and Novavax aims to distribute 51 million vaccines to Australia

The Pharma Data

When multiple mutations occur at the receptor-binding domain of the spike protein, it renders antibodies ineffective. Novavax’s vaccine is a recombinant protein vaccine adjuvanted with Novavax’s nanoparticle technology, Matrix-M, which enhances immune response in recipients. Download this exclusive report here.

article thumbnail

Systemic Lupus Erythematosus Treatment Market: How the Leading Companies are Countering the Rising Prevalence?

Delveinsight

It is sold under the brand name Plaquenil and is available only by prescription. Lupuzo is a medication that specifically modulates the immune system of lupus patients by changing the behaviour of some of the key cells involved in the disease’s pathogenesis. It is also available as a generic medicine. percent versus 48.8

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Thrombocytopenia Drugs Market: What Newer Agents Are Expected To Enter The Market?

Delveinsight

There are newer agents coming to the market, for instance, Fc receptor via monoclonal IgG antibodies mechanism, BTK [Bruton tyrosine kinase] inhibition, and so on, however, the real challenge lies in the compliance in terms of patients perspectives such as cost and tolerance.

article thumbnail

FDA clears Dupixent as first drug for rare skin disorder

pharmaphorum

The disorder – driven by type 2 inflammation characterised by an antibody-based immune response – causes hard lumps or nodules to form on the skin that are so itchy they can lead patients to scratch themselves to the point of bleeding or pain.

Drugs 69
article thumbnail

U.S. FDA APPROVES TICOVAC™, PFIZER’S TICK-BORNE ENCEPHALITIS (TBE) VACCINE

The Pharma Data

About TICOVAC (Tick-borne encephalitis vaccine) Pfizer’s TBE vaccine, marketed under the brand names FSME-Immun ® and TicoVac in Europe, and TICOVAC in the U.S., 7 It is able to induce neutralizing antibodies against the natural TBE virus, as the sequence and structure of the virus subtype match those found in nature.

article thumbnail

Cell-Mediated Therapies for Infectious Disease Summit

pharmaphorum

In the fight against emerging coronavirus variants and spike mutations, the need for long-lasting immunity is greater than ever. This is why the time is now to look beyond antibodies and capitalize on the long-term immune response of T cell therapies. Check out the brand-new event guide here.

article thumbnail

Herd immunity won’t stop the outbreak: 3 Dangerous Covid-19 Myths

Find Me Cure

Vandalizing cell towers is not going to get rid of this new virus in the corona family and avoiding certain brands of beer is not a good prevention strategy. . This means that in order for herd immunity to work, 50-70% of the world population needs to get infected and then develop antibodies. .